Suvretta Capital Management »

Avantor shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Avantor (AVTR) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Avantor

Tip: Access up to 7 years of quarterly data

All positions including Avantor held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avantor by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $806k 38k 21.08
2023-06-30 $786k 38k 20.54
2023-03-31 $326k 15k 21.14

More positions owned by Suvretta Capital Management

Royalty Pharma Shs Class A (RPRX)
Biohaven (BHVN)
Arcellx Common Stock (ACLX)
Horizon Therapeutics Pub L SHS
Insmed Com Par $.01 (INSM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Intra Cellular Therapies (ITCI)
Microsoft Corporation (MSFT)
Kura Oncology (KURA)
Wynn Resorts (WYNN)
Marinus Pharmaceuticals Com New (MRNS)
89bio (ETNB)
General Electric Com New (GE)

View all positions for Suvretta Capital Management

Top funds holding Avantor

Vanguard Group
Dodge & Cox
Robeco Investment Management
Barrow, Hanley, Mewhinney & Strauss
T. Rowe Price Associates
Henderson Group
New Mountain Capital
Millennium Management
Artemis Investment Management
Ubs Global Asset Management Americas
Parnassus Investments
Norges Bank Investment Management
Bessemer
Clarkston Capital Partners
SAM Sustainable Asset Management

View all funds holding Avantor